Natto & Nattokinase:
The Fermentation Science
Behind Japan's Cardiovascular Superfood

1. The Fermentation Biology of Bacillus subtilis var. natto

Natto is not simply fermented soybeans. It is the product of a highly specific microorganism — Bacillus subtilis var. natto — acting on a particular substrate under tightly controlled conditions. Understanding why natto produces compounds that other fermented foods do not requires tracing the entire fermentation biology from spore to finished product.

The Soybean as Substrate

Soybeans are selected over other legumes for a structural reason: their high protein content (~36% dry weight) and substantial isoflavone concentration provide both the nitrogen substrate for bacterial metabolism and secondary bioactive precursors. B. subtilis var. natto secretes extracellular proteases that hydrolyze soy proteins into free amino acids and peptides during fermentation. This proteolytic activity is, in fact, a precondition for nattokinase expression — the enzyme is produced partly as a response to the nitrogen-rich environment.

Steaming the beans (rather than boiling) is the traditional preparatory step. Steaming softens the seed coat enough for bacterial penetration while retaining a higher concentration of intact isoflavones and phytic acid than prolonged wet boiling would. The beans reach the fermenter at approximately 80–90°C and are inoculated while still warm.

Spore Germination and the 40°C Optimum

B. subtilis var. natto is a sporulating bacterium. Commercial starters are sold in endospore form — heat-resistant, metabolically dormant structures. Once applied to warm soybeans and placed into a fermenting chamber, the following sequence occurs:

1. Activation (~80°C, brief): Heat shock during inoculation pre-conditions spores for germination without killing them (the bacteria are added after the beans cool slightly to ~65–70°C).
2. Germination (50–60°C range): Spores transition from dormancy to vegetative cells, driven by l-alanine and purine nucleoside signals from the soybean surface.
3. Exponential growth (37–42°C optimal): Vegetative cells divide rapidly, colonizing the entire bean surface within 8–10 hours. The fermenter is held at approximately 40°C — the temperature optimum for both growth and nattokinase gene expression.
4. Maturation and biofilm formation (ongoing, 16–20 h total): Cells produce the characteristic viscous poly-glutamic acid (PGA) polymer — the sticky threads that define natto's texture — alongside nattokinase and menaquinones (vitamin K2 forms, primarily MK-7).

After fermentation, natto is refrigerated for 8–24 hours. This resting period is not cosmetic: it allows the PGA biopolymer to fully polymerize and nattokinase activity to peak as the bacterial cells complete their metabolic cycle and transition toward sporulation again.

Why Only B. subtilis var. natto

This is perhaps the most pharmacologically important distinction in natto science. Multiple other Bacillus subtilis strains exist — including widely used industrial and probiotic strains — yet none produce nattokinase at meaningful levels. The explanation lies in the gene cluster responsible for the enzyme. B. subtilis var. natto expresses the aprN gene (also called nkase), which encodes the 275-amino-acid serine alkaline protease that becomes nattokinase after post-translational processing. This gene's promoter is activated by specific regulatory circuits — particularly the degU and sinR transcription factors — that are differentially expressed in the natto variant compared to standard lab or industrial B. subtilis strains. Attempts to transfer nattokinase production to Lactobacillus or Saccharomyces species via recombinant expression have yielded functional protein in research settings, but commercial natto still relies exclusively on the original B. subtilis var. natto strain for regulatory and organoleptic reasons.

2. Vitamin K2 MK-7 Biosynthesis — Why Natto Is Unique

Vitamin K exists in two primary dietary forms: phylloquinone (K1, from plants) and menaquinones (K2, from bacteria and some animal products). Natto's distinction is not simply that it contains K2 — it's that it produces MK-7 (menaquinone-7), the long-chain menaquinone with the most favorable pharmacokinetic profile of all K2 forms.

The Menaquinone Biosynthesis Pathway

B. subtilis var. natto synthesizes MK-7 via the shikimate pathway, starting with chorismate as the precursor. The bacterial enzyme MenA performs the prenylation step, attaching a heptaprenyl side chain (7 isoprene units = MK-7) to the naphthoquinone ring system. The number of isoprene units in this side chain determines which menaquinone form is produced — B. subtilis naturally produces predominantly MK-7, whereas gut bacteria like Bacteroides produce shorter-chain forms (MK-10, MK-11) and dairy fermentation bacteria produce primarily MK-4.

Natto's MK-7 content is extraordinary: approximately 800–1,100 µg per 100 g of fresh natto, depending on fermentation time and strain. For reference:

• Hard cheese: 40–80 µg MK-4 + MK-9 per 100 g
• Fermented soft cheese: 20–50 µg per 100 g
• Yogurt: 2–5 µg per 100 g
• Egg yolk: ~32 µg MK-4 per 100 g

Why MK-7 Half-Life Matters: 72 Hours vs. 1–2 Hours

Vitamin K1 (phylloquinone) is rapidly cleared from the bloodstream — its plasma half-life is approximately 1–2 hours. This means K1 from leafy greens produces a transient peak that declines before it can exert sustained carboxylation effects on extrahepatic tissues like bone and arteries.

MK-7, by contrast, has a plasma half-life of approximately 68–72 hours (approximately 3 days). This is attributable to two structural differences: (1) the long hydrophobic side chain allows MK-7 to associate with LDL and VLDL lipoprotein particles, dramatically extending its circulation time; (2) MK-7 has superior bioavailability from the gut, with absorption estimated at 2–10× that of K1 at equivalent doses.

The clinical consequence of this extended half-life is that a single daily serving of natto (or a daily MK-7 supplement dose of 90–360 µg) maintains sustained tissue carboxylation, whereas achieving equivalent sustained K2 tissue saturation from K1 would require multiple daily doses of leafy greens.

Carboxylation of Clotting Factors and MGP

Vitamin K2 MK-7 functions as the essential cofactor for the enzyme gamma-glutamyl carboxylase (GGCX). GGCX carboxylates specific glutamic acid residues on vitamin K-dependent proteins, converting them to gamma-carboxyglutamic acid (Gla) residues capable of binding calcium ions. The targets include:

• Coagulation factors II, VII, IX, X: Hepatic carboxylation activates these factors — which is why warfarin (a K antagonist) is anticoagulant. Note: this means natto can interfere with warfarin therapy (see Practical Guide, Section 5).
• Matrix Gla Protein (MGP): An extrahepatic protein expressed in vascular smooth muscle cells and chondrocytes. Fully carboxylated (activated) MGP inhibits soft tissue calcification — particularly arterial calcification. Undercarboxylated MGP (ucMGP) is associated with vascular calcification and arterial stiffness. MK-7 supplementation at 180 µg/day for 3 years was shown in the MaasVallei trial to significantly reduce ucMGP and improve arterial stiffness in postmenopausal women.
• Osteocalcin: Bone matrix protein that, when fully carboxylated by K2, effectively binds hydroxyapatite and supports bone mineralization. Epidemiological data from Japan correlate high natto intake with lower hip fracture rates in women.

3. Nattokinase — The Serine Protease at the Heart of Natto Science

Nattokinase (NK, EC 3.4.21.62) is the compound that gave natto its modern reputation as a cardiovascular food. Its discovery story is unusually well-documented and begins with a single experiment in 1987.

The Sumi 1987 Discovery

Hiroyuki Sumi, then a graduate researcher at the University of Chicago, was screening various foods for thrombolytic activity using a standard fibrin plate assay. The procedure: a layer of fibrin (the structural protein of blood clots) is cast into an agar plate. Test material is placed on the fibrin layer. If proteolytic/thrombolytic activity is present, a clear halo forms as the fibrin is dissolved. Sumi had tested dozens of foods without significant results when he placed a sample of natto on the plate — and returned hours later to find the largest dissolution zone he had yet observed. Nattokinase had dissolved the fibrin clot significantly faster than any other tested substrate, including plasmin (the body's own primary fibrinolytic enzyme) at equivalent concentrations.

Sumi's original 1987 publication in Experientia established that the active compound was a bacterial serine protease — later isolated, sequenced, and named nattokinase. The paper spawned a research field that now encompasses over 200 published studies.

Serine Protease Classification and Structure

Nattokinase belongs to the subtilisin family of serine proteases — the same enzyme family as the digestive enzyme subtilisin, common in detergent enzymes, but with distinct substrate specificity. The enzyme's active site contains the canonical serine-histidine-aspartate catalytic triad. It is a 275-amino-acid, single-chain protein with a molecular weight of ~27.7 kDa, and it is produced as a pre-pro-enzyme (417 amino acids including signal peptide and propeptide) that undergoes autocatalytic processing to its mature active form.

What distinguishes nattokinase from other subtilisin-family enzymes is its strong preference for the fibrin substrate — the protein matrix of blood clots — combined with its capacity to activate endogenous fibrinolytic pathways. Potency is expressed in fibrinolytic units (FU), standardized such that 4 FU = 1 plasmin equivalent (PE). Commercial nattokinase supplements typically provide 2,000–5,000 FU per capsule.

Fibrin Degradation Kinetics and Mechanism

Nattokinase acts on the fibrinolytic cascade through at least three documented mechanisms:

1. Direct fibrinolysis: NK cleaves fibrin directly, particularly at lysine residues exposed in cross-linked fibrin polymers. It also degrades fibrin fragments D and E — the degradation products that signal ongoing thrombolysis.
2. tPA activation: Nattokinase upregulates tissue plasminogen activator (tPA) production by endothelial cells, amplifying the body's own fibrinolytic capacity. tPA converts plasminogen to plasmin, which is the primary endogenous fibrin-degrading enzyme.
3. PAI-1 inhibition: Plasminogen activator inhibitor-1 (PAI-1) is the main physiological brake on fibrinolysis. Elevated PAI-1 is a recognized cardiovascular risk factor. Nattokinase degrades PAI-1 directly, releasing the inhibitory brake on tPA and thus amplifying net fibrinolytic activity beyond what nattokinase's direct action alone would achieve. This PAI-1 degradation effect is now considered one of nattokinase's most clinically relevant mechanisms.

Oral Bioavailability: Can an Enzyme Survive Digestion?

The most common objection to oral nattokinase is the proteolytic gastrointestinal environment: if nattokinase is itself a protein, how does it survive stomach acid and pancreatic proteases to reach systemic circulation? The evidence suggests partial but meaningful survival. Animal studies using radiolabeled nattokinase have demonstrated measurable intact enzyme in plasma after oral administration. Human pharmacokinetic data are limited, but multiple RCTs showing fibrinolytic effects after oral NK supplementation imply either direct absorption or downstream enzymatic activity on gut-accessible substrates that then propagate systemic effects. The acid-resistant enteric coating used in some supplements is designed to maximize intestinal (rather than gastric) absorption.

4. Cardiovascular Evidence — Key Studies

The cardiovascular research on nattokinase has matured considerably since Sumi 1987. Below is a structured review of the most clinically relevant studies.

Blood Pressure Mechanism

The blood pressure reduction observed in multiple nattokinase trials is not fully explained by fibrinolysis alone. Proposed mechanisms include: (1) degradation of angiotensin-I and angiotensin-II by nattokinase's ACE-like peptidase activity; (2) improvement in endothelial function secondary to reduced fibrinogen and improved microvascular flow; (3) vasoactive peptides released from soy protein hydrolysis during fermentation acting as angiotensin-converting enzyme (ACE) inhibitors. The relative contribution of each mechanism remains under investigation.

5. Practical Guide — How to Eat Natto, Supplementation, and Who Should Be Careful

Eating Natto: Texture, Flavor, and Preparation

Natto's initial challenge for non-Japanese eaters is almost entirely textural and olfactory rather than flavor-based. The fermented ammonia notes and the stringy poly-glutamic acid threads are the two barriers. Both become more manageable with the right preparation:

• Stir vigorously before serving. Stirring 40–50 times with chopsticks or a fork increases PGA thread formation and paradoxically smooths the texture into a creamier consistency. This is the traditional preparation method and it works.
• Use the included tare sauce and mustard. Pre-packaged natto (common in Japanese grocery stores, Korean markets, and Asian supermarkets) includes a soy-based tare and hot mustard. Both balance the ammonia notes with salt and sharp heat.
• Serve over hot rice. The heat of freshly cooked rice mellows the ammonia aroma slightly and the starch substrate complements the umami profile. This is the standard Japanese preparation: natto-gohan (natto on rice).
• Flavor pairings that work: Chopped green onion, raw egg yolk, toasted sesame seeds, furikake seasoning, kimchi (Korean fermented cabbage — doubles fermented probiotic load), grated ginger, togarashi chili flakes.
• Temperature matters: Natto straight from the refrigerator is more pungent. Allow it to sit at room temperature for 10–15 minutes before serving to mellow the sharp fermentation notes.
• Beyond rice: Natto works in miso soup, rolled into nori (seaweed) hand rolls, in soba noodle bowls, and — unconventionally but effectively — on avocado toast with ponzu drizzle.

Vitamin K2 Content Per Serving

One standard Japanese serving of natto is 40–50 g (one styrofoam or polystyrene container). At ~1,000 µg MK-7 per 100 g, a single serving provides approximately 400–500 µg MK-7. For context, clinical studies showing cardiovascular and bone benefits with MK-7 supplementation typically use 90–360 µg/day. Natto provides 1–5× these study doses from food alone.

Nattokinase: Food vs. Supplement Form

Nattokinase content in food natto is approximately 100–200 mg of active enzyme per 100 g, equivalent to roughly 1,500–3,000 FU per 100 g serving. Commercial nattokinase supplements standardized to 2,000–5,000 FU per capsule deliver roughly equivalent or higher activity than a food serving, but without the co-present K2, probiotics, and soy isoflavones that food natto provides. For individuals who cannot tolerate natto's texture or smell, supplementation is a reasonable proxy for nattokinase benefits specifically — but it does not replicate the full MK-7 dose from food.

Who Should Be Careful

People on warfarin (Coumadin) or other vitamin K antagonists: This is the primary contraindication for food natto — not for nattokinase supplements. Natto's exceptionally high MK-7 content (400–500 µg per serving) directly antagonizes warfarin's mechanism and can dramatically alter INR (international normalized ratio), increasing clot risk. Even a single serving of natto can destabilize INR for days due to MK-7's 72-hour half-life. Patients on warfarin must avoid food natto entirely and discuss nattokinase supplements (which contain minimal K2 if properly processed) with their anticoagulation clinic.

People on antiplatelet or anticoagulant medications other than warfarin (aspirin, clopidogrel, rivaroxaban, apixaban): The fibrinolytic activity of nattokinase may theoretically add to antiplatelet or anticoagulant drug effects. Consult your physician before supplementing with nattokinase if taking these medications.

Soy allergy: Natto is a soy product. Food natto is contraindicated with soy allergy. Purified nattokinase supplements, if manufactured to remove soy proteins, may be tolerable but this should be confirmed with an allergist and verified by the specific product's manufacturing documentation.

Pregnancy: High-dose vitamin K2 supplementation during pregnancy has not been adequately studied. Moderate food intake of natto is likely safe, but large quantities specifically for MK-7 loading should be discussed with an obstetrician.